Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Powershares S&P 500 High Divide | SPHD | Sep 26, 2024 | 50.08 | +0.14 |
Powershares S&P Midcap Low Vola | XMLV | Sep 26, 2024 | 60.79 | +0.33 |
Powershares S&P Smallcap Low Vo | XSLV | Sep 26, 2024 | 47.76 | +0.42 |
PowerShares Variable Rate Investment Grade Portfolio | VRIG | Sep 26, 2024 | 25.09 | +0.04 |
PowerUp Acquisition A | PWUP | Sep 26, 2024 | 11.59 | 0.00 |
PowerUp Acquisition Unit | PWUPU | Sep 26, 2024 | 11.51 | -2.54 |
PPG Industries | PPG | Sep 26, 2024 | 134.55 | +5.25 |
PPL | PPL | Sep 26, 2024 | 32.60 | -0.43 |
PRA Group | PRAA | Sep 26, 2024 | 23.23 | +2.97 |
Prairie Operating | PROP | Sep 26, 2024 | 8.20 | -3.42 |
Praxis Precision Medicines | PRAX | Sep 26, 2024 | 57.79 | -0.79 |
Precigen | PGEN | Sep 26, 2024 | 0.91 | -1.23 |
Precipio | PRPO | Sep 26, 2024 | 6.54 | +0.67 |
Precision BioSciences | DTIL | Sep 26, 2024 | 9.11 | -0.22 |
Precision Drilling | PDS | Sep 26, 2024 | 60.66 | -3.15 |
Precision Optics | POCI | Sep 26, 2024 | 6.14 | +5.14 |
Predictive Oncology | POAI | Sep 26, 2024 | 0.76 | -4.10 |
Preferred Bank | PFBC | Sep 26, 2024 | 79.48 | +0.44 |
Preferred Portfolio Powershares | PGX | Sep 26, 2024 | 12.44 | -0.08 |
Preformed Line Products | PLPC | Sep 26, 2024 | 130.48 | +3.25 |
Prelude Therapeutics | PRLD | Sep 26, 2024 | 2.21 | +6.25 |
Premier A | PINC | Sep 26, 2024 | 19.85 | +3.76 |
Premier Financial | PFC | Sep 26, 2024 | 23.09 | +0.22 |
Prenetics Global A | PRE | Sep 26, 2024 | 4.19 | +6.89 |
Presidio Property Trust A | SQFT | Sep 26, 2024 | 0.67 | +0.01 |
Presidio Property Trust D Pref | SQFTP | Sep 26, 2024 | 15.60 | -1.08 |
Prestige Consumer Healthcare | PBH | Sep 26, 2024 | 71.35 | +0.81 |
Prestige Wealth | PWM | Sep 26, 2024 | 0.77 | +1.32 |
PriceSmart | PSMT | Sep 26, 2024 | 89.49 | +0.64 |
Prime Medicine | PRME | Sep 26, 2024 | 3.56 | +4.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.